Non-Invasive Diagnosis of Glioblastoma Using Micro-Rna and Tumor-Educated Platelets: A Review of Emerging Biomarkers
References
- Gatto L, Franceschi E, Di Nunno V, Tosoni A, Lodi R, Brandes AA. Liquid biopsy in glioblastoma management: from current research to future perspectives. Oncologist. 2021;26(10):865-878.
- Najafi S, Asemani Y, Majidpoor J, Mahmoudi R, Aghaei-Zarch SM, Mortezaee K. Tumor-educated platelets. Clin Chim Acta. 2024;552:117690.
- Bardelli A, Pantel K. Liquid biopsies, what we do not know (yet). Cancer Cell. 2017;31, 172:179.
- Joosse S, Pantel K. Tumor-educated platelets as a liquid biopsy in cancer patients. Cancer Cell. 2015;28:552-554.
- McAllister SS, Weinberg RA. The tumor-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol. 2014;16:717-727.
- D’Ambrosi S, Nilsson RJ, Wurdinger T. Platelets and tumor-associated RNA transfer. Blood. 2021;137(23):3181-3191.
- Tjon-Kon-Fat LA, Lundholm M, Schröder M, Wurdinger T, Thellenberg-Karlsson C, Widmark A, Wikström P, Nilsson RJA. Platelets harbor prostate cancer biomarkers and the ability to predict therapeutic response to abiraterone in castration resistant patients. Prostate. 2018;78(1):48-53.
- Klement GL, Yip TT, Cassiola F, Kikuchi L, Cervi D, Podust V, Italiano JE, Wheatley E, Abou-Slaybi A, Bender E, Almog N, Kieran MW, Folkman J. Platelets actively sequester angiogenesis regulators. Blood. 2009;113(12):2835-2842.
- Best MG, Sol N, Kooi I, Tannous J, Westerman BA, Rustenburg F, Schellen P, Verschueren H, Post E, Koster J, Ylstra B, Ameziane N, Dorsman J, Smit EF, Verheul HM, Noske DP, Reijneveld JC, Nilsson RJA, Tannous BA, Wesseling P, Wurdinger T. RNA-Seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics. Cancer Cell. 2015;28(5):666-676.
- Sheng ML, Dong ZH, Xie YP. Identification of tumor-educated platelet biomarkers of non-small-cell lung cancer. Onco Targets Ther. 2018;11:8143-8151.
- Calverley DC, Phang TL, Choudhury QG, Gao B, Oton AB, Weyant MJ, Geraci MW. Significant downregulation of platelet gene expression in metastatic lung cancer. Clin Transl Sci. 2010;3(5):227-232.
- de Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374-403.
- Schwertz H, Tolley ND, Foulks JM, Denis MM, Risenmay BW, Buerke M, Tilley RE, Rondina MT, Harris EM, Kraiss LW, Mackman N, Zimmerman GA, Weyrich AS. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med. 2006;203(11):2433-2440.
- Alhasan AA, Izuogu OG, Al-Balool HH, Steyn JS, Evans A, Colzani M, Ghevaert C, Mountford JC, Marenah L, Elliott DJ, Santibanez-Koref M, Jackson MS. Circular RNA enrichment in platelets is a signature of transcriptome degradation. Blood. 2016;127(9):e1-e11.
- Wei L, Li S, Zhang P, Hu T, Zhang MQ, Xie Z, Wang X. Characterizing microRNA-mediated modulation of gene expression noise and its effect on synthetic gene circuits. Cell Rep. 2021;36(8):109573.
- Bertoli G, Cava C, Castiglioni I. MicroRNAs: new biomerkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics. 2015;5(10):1122-1143.
- Yang CS, Rana TM. Learning the molecular mechanisms of the reprogramming factors: let start microRNAs. Mol Byosyst. 2013;9:10-17.
- Kalkan R, Atli Eİ. The impacts of miRNAs in glioblastoma progression. Crit Rev Eukaryot Gene Expr. 2016;26:137-142.
- Roth P, Wischhusen J, Happold C, Chandran PA, Hofer S, Eisele G, Weller M, Keller A. A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem. 2011;118(3):449-457.
- Srinivasan S, Patric IR, Somasundaram K. A ten-microRNA expression signature predicts survival in glioblastoma. PLoS One. 2011;6(3):e17438.
- Tang H, Liu Q, Liu X, Ye F, Xie X, Xie X, Wu M. Plasma miR-185 as a predictive biomarker for prognosis of malignant glioma. J Cancer Res Ther. 2015;11(3):630-634.
- Lai NS, Wu DG, Fang XG, Lin YC, Chen SS, Li ZB, Xu SS. Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma. Br J Cancer. 2015;112(7):1241-1246.
- Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803-820.
- Mansouri A, Hachem LD, Mansouri S, Nassiri F, Laperriere NJ, Xia D, Lindeman NI, Wen PY, Chakravarti A, Mehta MP, Hegi ME, Stupp R, Aldape KD, Zadeh G. MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges. Neuro Oncol. 2019;21(2):167-178.
- Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009;27(28):4733-4740.
- Siravegna G, Marsoni S, Siena S, Bardelli A. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017;14:531-548.
- Sol N, Veld S, Vancura A et al. Tumor-educated platelets RNA for the detection and (pseudo)progression monitoring of glioblastoma. Cell Reports Medicine. 2020;1:100101.
- Wang Y, Zhang H, Li H, Xiong J, Wang J, Huang Y. Application of tumor-educated platelets as new fluid biopsy markers in various tumors. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex. 2023;25:114-125.
- Du W, Liu J, Zhu S, He S, Liu Z, Yao Y, Qibin S. Unveiling the hidden role of tumor-educated platelets in cancer: a promising marker for early diagnosis and treatment. Oncologie. 2025;27(3):327-342.
- Makowska M, Smolarz B, Romanowicz H. microRNAs (miRNAs) in glioblastoma multiforme (GBM)-recent literature review. Int J Mol Sci. 2023;24:3521.
- Valle-Garcia D, Pérez de la Cruz V, Flores I, Salazar A, Pineda B, Meza-Sosa KF. Use of microRNAs as diagnostic, prognostic, and therapeutic tools for glioblastoma. Int J Mol Sci. 2024;25(5):2464.
- Bayona C, Ranđelović T, Olaizola-Rodrigo C, Ochoa I. Microfluidic approaches for liquid biopsy in glioblastoma: Insights into diagnostic and follow-up strategies. Bioeng Transl Med. 2026;11(2):e70032.
- Orzan F, De Bacco F, Lazzarini E, Crisafulli G, Gasparini A, Dipasquale A, Barault L, Macagno M, Persico P, Pessina F, Bono B, Giordano L, Zeppa P, Melcarne A, Cassoni P, Garbossa D, Santoro A, Comoglio PM, Indraccolo S, Simonelli M, Boccaccio C. Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation. Clin Cancer Res. 2023;29(7):1252-1266.
- Wasiak T, Jaskólska M, Filiks K, Bartkowiak J, Rutkowska A. Decoding glioblastoma through liquid biopsy: molecular insights and clinical prospects. Cell. 2026;15(3):309.
- Schmidl B, Wei K, Ghasemimehr N, Dezfouli AB, Wollenberg B. Tumor-educated platelets as liquid biopsy: uncovering the mechanisms of cancer progression. Crit Rev Oncol Hematol. 2025;218:105106.
- Bauman MMJ, Bouchal SM, Monie DD, Aibaidula A, Singh R, Parney IF. Strategies, considerations, and recent advancements in the development of liquid biopsy for glioblastoma: A step towards individualized medicine in glioblastoma. Neurosurg Focus. 2022;53:E14.
- Tataranu LG. Liquid biopsy as a diagnostic and monitoring tool in glioblastoma. Medicina (Kaunas). 2025;61(4):716.
Language: English
Page range: 1 - 5
Published on: Jul 11, 2026
Published by: Ovidius University of Constanta
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Diana Badiu, Costel-Stelian Brînzan, Mariana Așchie, Gabriela-Izabela Bălțătescu, Anca-Florentina Mitroi, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution 4.0 License.